
Jiangsu Kanion Pharmaceutical Co.,Ltd.
SSE:600557.SS
13.78 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,897.669 | 4,867.807 | 4,350.872 | 3,648.57 | 3,031.926 | 4,565.798 | 3,823.805 | 3,274.698 | 3,000.278 | 2,820.446 | 2,562.928 | 2,230.303 | 1,903.374 | 1,537.778 | 1,358.308 | 968.533 | 1,132.031 | 998.635 | 852.7 | 802.419 | 560.144 | 369.943 | 262.057 | 225.433 | 156.559 | 100.415 |
Cost of Revenue
| 1,043.897 | 1,255.293 | 1,214.086 | 1,025.028 | 821.689 | 998.915 | 904.941 | 793.697 | 760.742 | 713.822 | 645.435 | 565.011 | 472.115 | 425.439 | 370.827 | 244.276 | 431.049 | 434.362 | 349.738 | 351.759 | 221.153 | 116.565 | 62.971 | 53.845 | 45.562 | 28.581 |
Gross Profit
| 2,853.771 | 3,612.514 | 3,136.786 | 2,623.542 | 2,210.237 | 3,566.883 | 2,918.864 | 2,481.001 | 2,239.536 | 2,106.625 | 1,917.494 | 1,665.292 | 1,431.259 | 1,112.338 | 987.481 | 724.256 | 700.982 | 564.273 | 502.961 | 450.66 | 338.992 | 253.378 | 199.086 | 171.588 | 110.996 | 71.834 |
Gross Profit Ratio
| 0.732 | 0.742 | 0.721 | 0.719 | 0.729 | 0.781 | 0.763 | 0.758 | 0.746 | 0.747 | 0.748 | 0.747 | 0.752 | 0.723 | 0.727 | 0.748 | 0.619 | 0.565 | 0.59 | 0.562 | 0.605 | 0.685 | 0.76 | 0.761 | 0.709 | 0.715 |
Reseach & Development Expenses
| 638.104 | 771.69 | 605.73 | 499.388 | 380.422 | 442.637 | 292.78 | 236.602 | 266.885 | 266.545 | 225.925 | 203.707 | 186.244 | 160.864 | 145.206 | 0 | 0 | 0 | 0 | 0 | 18.937 | 0 | 0 | 20.174 | 5.242 | 0 |
General & Administrative Expenses
| 109.997 | 177.344 | 83.296 | 61.219 | 58.035 | 76.703 | 49.595 | 51.172 | 53.958 | 45.64 | 51.809 | 58.202 | 37.387 | 30.155 | 39.452 | 144.982 | 139.356 | 117.735 | 100.902 | 101.598 | 32.623 | 54.91 | 64.962 | 22.594 | 12.84 | 18.842 |
Selling & Marketing Expenses
| 1,255.341 | 1,936.944 | 1,867.832 | 1,583.08 | 1,302.341 | 2,275.344 | 1,888.338 | 1,565.884 | 1,340.605 | 1,214.828 | 1,091.062 | 941.371 | 802.722 | 622.712 | 546.73 | 402.806 | 382.396 | 300.56 | 294.491 | 260.366 | 186.121 | 140.549 | 102.768 | 83.239 | 59.313 | 37.179 |
SG&A
| 1,365.338 | 2,114.287 | 1,951.128 | 1,644.298 | 1,360.376 | 2,352.047 | 1,937.933 | 1,617.056 | 1,394.563 | 1,260.468 | 1,142.871 | 999.573 | 840.109 | 652.867 | 586.182 | 547.788 | 521.752 | 418.295 | 395.394 | 361.964 | 218.744 | 195.459 | 167.73 | 105.833 | 72.152 | 56.021 |
Other Expenses
| 465.812 | 165.516 | 137.933 | 127.729 | 99.742 | 159.481 | -4.623 | -3.049 | 43.935 | 20.521 | 12.24 | 40.697 | 31.583 | 30.777 | 19.847 | 18.084 | 6.36 | 6.866 | 2.309 | 1.469 | 2.082 | 0.844 | -0.383 | -1.02 | -3.312 | -0.133 |
Operating Expenses
| 2,469.254 | 3,048.722 | 2,694.792 | 2,271.416 | 1,840.54 | 2,954.165 | 2,381.777 | 1,990.095 | 1,808.805 | 1,659.866 | 1,485.413 | 1,300.894 | 1,129.874 | 885.58 | 783.841 | 562.03 | 536.848 | 430.07 | 405.543 | 371.035 | 273.655 | 200.561 | 171.775 | 144.633 | 89.492 | 57.389 |
Operating Income
| 384.517 | 563.792 | 454.811 | 350.983 | 351.422 | 578.915 | 500.626 | 441.952 | 386.776 | 398.718 | 361.666 | 306.787 | 242.918 | 183.023 | 183.675 | 159.36 | 150.133 | 113.018 | 84.65 | 66.841 | 57.643 | 52.113 | 26.919 | 26.153 | 19.902 | 10.297 |
Operating Income Ratio
| 0.099 | 0.116 | 0.105 | 0.096 | 0.116 | 0.127 | 0.131 | 0.135 | 0.129 | 0.141 | 0.141 | 0.138 | 0.128 | 0.119 | 0.135 | 0.165 | 0.133 | 0.113 | 0.099 | 0.083 | 0.103 | 0.141 | 0.103 | 0.116 | 0.127 | 0.103 |
Total Other Income Expenses Net
| 0.247 | -12.81 | -9.135 | -22.737 | -56.998 | -3.56 | -21.955 | -36.984 | 42.708 | -24.642 | -57.553 | -15.558 | -24.191 | -6 | 0.855 | 18.084 | 6.36 | -14.32 | -15.72 | -15.032 | -1.474 | -0.611 | -1.15 | -1.378 | -3.705 | -0.133 |
Income Before Tax
| 384.764 | 550.983 | 445.717 | 328.266 | 294.424 | 575.355 | 496.002 | 438.903 | 429.485 | 418.769 | 372.523 | 346.584 | 274.501 | 213.799 | 203.522 | 177.444 | 156.493 | 119.884 | 84.291 | 66.451 | 56.26 | 51.503 | 25.769 | 24.776 | 16.197 | 10.164 |
Income Before Tax Ratio
| 0.099 | 0.113 | 0.102 | 0.09 | 0.097 | 0.126 | 0.13 | 0.134 | 0.143 | 0.148 | 0.145 | 0.155 | 0.144 | 0.139 | 0.15 | 0.183 | 0.138 | 0.12 | 0.099 | 0.083 | 0.1 | 0.139 | 0.098 | 0.11 | 0.103 | 0.101 |
Income Tax Expense
| 3.841 | 3.932 | 3.799 | 3.916 | 20.398 | 58.842 | 58.4 | 60.721 | 53.339 | 53.526 | 49.413 | 45.901 | 34.363 | 24.337 | 20.309 | 17.044 | 13.499 | 22.316 | 19.076 | 16.562 | 8.604 | 14.689 | 4.839 | 6.322 | 4.801 | 4.595 |
Net Income
| 391.862 | 536.733 | 434.467 | 320.544 | 262.923 | 506.993 | 431.386 | 373.783 | 373.741 | 362.336 | 319.614 | 297.018 | 239.671 | 182.508 | 180.729 | 160.268 | 141.94 | 96.358 | 64.023 | 48.845 | 47.231 | 36.737 | 20.875 | 18.318 | 11.421 | 5.569 |
Net Income Ratio
| 0.101 | 0.11 | 0.1 | 0.088 | 0.087 | 0.111 | 0.113 | 0.114 | 0.125 | 0.128 | 0.125 | 0.133 | 0.126 | 0.119 | 0.133 | 0.165 | 0.125 | 0.096 | 0.075 | 0.061 | 0.084 | 0.099 | 0.08 | 0.081 | 0.073 | 0.055 |
EPS
| 0.68 | 0.93 | 0.75 | 0.56 | 0.44 | 0.86 | 0.73 | 0.63 | 0.61 | 0.59 | 0.53 | 0.5 | 0.4 | 0.31 | 0.3 | 0.27 | 0.24 | 0.26 | 0.11 | 0.087 | 0.067 | 0.052 | 0.03 | 0.033 | 0.02 | 0.01 |
EPS Diluted
| 0.68 | 0.93 | 0.75 | 0.56 | 0.44 | 0.86 | 0.73 | 0.63 | 0.61 | 0.59 | 0.53 | 0.5 | 0.4 | 0.31 | 0.3 | 0.27 | 0.24 | 0.26 | 0.11 | 0.087 | 0.067 | 0.052 | 0.03 | 0.033 | 0.02 | 0.01 |
EBITDA
| 606.703 | 743.165 | 637.462 | 531.115 | 478.988 | 782.147 | 692.764 | 644.319 | 614.612 | 548.139 | 490.927 | 467.476 | 336.579 | 267.764 | 257.08 | 218.957 | 203.596 | 181.426 | 140.885 | 117.37 | 90.261 | 67.748 | 34.022 | 30.776 | 23.051 | 14.444 |
EBITDA Ratio
| 0.156 | 0.153 | 0.147 | 0.146 | 0.158 | 0.171 | 0.181 | 0.197 | 0.205 | 0.194 | 0.192 | 0.21 | 0.177 | 0.174 | 0.189 | 0.226 | 0.18 | 0.182 | 0.165 | 0.146 | 0.161 | 0.183 | 0.13 | 0.137 | 0.147 | 0.144 |